Why the study?
Elevated oxygen tension during hyperbaric oxygen therapy is only present transiently, motivating the investigation of possible prevailing vascular changes caused by the therapy.
A novel measuring suite using synchronous ECG and PPG for Pulse Transit Time analysis was successfully developed and validated for monitoring vascular responses during hyperbaric oxygen therapy.
Device enables vascular monitoring during HBOT; leaves open whether sustained changes contribute to wound healing beyond brief oxygen exposure.
The efficacy of hyperbaric oxygen therapy in treating wound healing disorders is well established. The obvious explanation is the presence of elevated oxygen tissue tensions during the high-pressure oxygen exposure. This explanation omits that the effective agent, elevated oxygen tension, is only present for 6.25% of the time. To investigate possible prevailing vascular changes caused by HBOT, the presented device monitors the vascular response during therapy by Pulse-Transit-Time analysis. The device allows synchronous 1 kHz ECG and PPG measurements. The data are stored in a 1 GBit flash drive and retrieved post-therapy. Normoxic measurements on the authors with and without nicotine validate the device's functionality. Measurements during HBO therapy have been successfully performed.
No takes yet. Share an insight, caveat, or question.
Wandel et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: